Axsome Therapeutics Inc Revenue per Employee (AXSM), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Axsome Therapeutics Inc   (NASDAQ: AXSM)
 

Axsome Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 45.54% in the second quarter 2026, year on year to cumulative value of $777 million, Axsome Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 839,534, this marks a new company high.
Within the Healthcare sector Employees of 110 other companies have achieved higher revenue per employee. While Axsome Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 753 to 1100. Axsome Therapeutics Inc has 925 employees.


What is Sales per Employee Ratio?







AXSM Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 45.54 % 57.42 % 65.03 % 63.22 % 72.13 %
Sales per Employee (TTM) $ 839,534 765,661 690,266 606,771 535,171
AXSM's Total Ranking # 1100 # 753 # 140 # 22 # 32
Seq. Revenue Change 14.21 % -2.45 % 14.62 % 13.96 % 23.53 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 76
Healthcare Sector # 111
Overall Market # 1100

Revenue per Employee Statistics
High Average Low
$ 839,534 $ 458,690 $ 156,338
(Jun 30 2026)   (Mar 31 2023)



Financial Statements
Axsome Therapeutics Inc 's Revenue MRQ $ 218 Millions Visit AXSM's Income Statement
Axsome Therapeutics Inc 's Revenues TTM $ 777 Millions Visit AXSM's aggregate revenue growth
What are AXSM's Sales? Visit AXSM's Sales by Segment




Other Ratios
Axsome Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AXSM's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AXSM's Competitors
Revenue per Employee for AXSM's Suppliers
Revenue per Employee for AXSM's Customers

You may also want to know
AXSM's Sales Growth Rates AXSM's Pe Price to earnings ratio AXSM's Receivables Turnover Ratio AXSM's Stock Quote
AXSM's Net Income Growth Rates AXSM's Ps Price to Sales ratio AXSM's Sales per Employee AXSM's Asset Turnover Ratio
AXSM's Net Margin AXSM's Pb Price to Book ratio AXSM's Financial Strength Ratios AXSM's Dividend Payout Ratio
Date modified: 2026-08-14T16:48:15+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Emergent Biosolutions Inc   855,777.78 $ 770.200  Million 900 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.